Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis "ATTEST2"

Not yet recruiting

Phase 3 Results N/A

Summary of Purpose

The principle research question is: in patients with acute ischaemic stroke eligible for intravenous (IV) thrombolysis, is tenecteplase superior in efficacy to alteplase, based on functional outcome as assessed by modified Rankin Scale distribution at day 90?

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2016.

1 Oct 2016 23 Jun 2016 1 Aug 2019 1 Aug 2019 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Parallel Assignment